Biotech
Eisai Co., Ltd.
1
Articles
Mentioned
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
0.95
Relevance Score
Coverage Timeline
April 2026
FDA Accelerated Approval Crackdown Shifts the Landscape for Aduhelm and Alzheimer's Pipeline
Policy
Mentioned
Apr 11, 2026
At investor conferences, Roche and Eisai have both quietly trimmed peak sales forecasts for their amyloid assets by as much as 40 percent.